Mabcampath and pyrexia Patient Reports February 11, 2012

Mabcampath Side Effects Report #4615955-X
Mabcampath side effect was reported by a Physician from on Mar 07, 2005. Male patient was diagnosed with t-cell lymphoma and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: confusional state, epilepsy , infection , postictal state, pyrexia. Mabcampath dosage: 30 MG, INTRAVENOUS. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #5756486-3
Mabcampath side effect was reported by a Consumer or non-health professional from FRANCE on May 21, 2008. Male patient, 39 years of age, was diagnosed with mycosis fungoides and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: dermatitis exfoliative, pyrexia. Mabcampath dosage: unknown. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #5150297-8
Mabcampath side effect was reported by a Health Professional from NETHERLANDS on Oct 26, 2006. Female patient, 80 years of age, was diagnosed with chronic lymphocytic leukaemia, pyrexia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: hyperkinesia, pyrexia, refusal of treatment by patient, restlessness. Mabcampath dosage: 3.10,30 MG, 1 DOSE 30 MG 3/WEEK, SUBCUTANEOUS. During the same period patient was treated with HYDROCORTISON, TAVEGIL, ACTONEL, CALCICHEW, FAMVIR. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #5150314-5
Mabcampath side effect was reported by a Health Professional from NETHERLANDS on Oct 26, 2006. Female patient, 80 years of age, was diagnosed with chronic lymphocytic leukaemia, pyrexia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: hyperkinesia, pyrexia, refusal of treatment by patient, restlessness. Mabcampath dosage: 3,10,30 M, 1 DOSE 30 MG 3/WEEK, SUBCUTANEOUS. During the same period patient was treated with HYDROCORTISON, TAVEGIL, ACTONEL, CALCICHEW, FAMVIR. Patient was hospitalized. Patient recovered.


Mabcampath Side Effects Report #6038164-9
Mabcampath side effect was reported by a Consumer or non-health professional from FRANCE on Jan 05, 2009. Female patient, 80 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: erythema, oedema peripheral, pain in extremity, pruritus, pyrexia, rash , skin lesion. Mabcampath dosage: unknown. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #6041914-9
Mabcampath side effect was reported by a Consumer or non-health professional from FRANCE on Jan 08, 2009. Female patient, 80 years of age, was diagnosed with chronic lymphocytic leukaemia, osteoarthritis  and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: erythema, fatigue, headache , oedema peripheral, pain in extremity, pruritus, pyrexia, rash , skin lesion. Mabcampath dosage: unknown. During the same period patient was treated with KETOPROFEN. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #5755292-3
Mabcampath side effect was reported by a Consumer or non-health professional from FRANCE on May 21, 2008. Male patient, 70 years of age, was diagnosed with chronic lymphocytic leukaemia, prophylaxis and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: adenoviral hepatitis, hepatic encephalopathy, hepatic failure, infection , lymphopenia, pyrexia, renal failure acute. Mabcampath dosage: unknown. During the same period patient was treated with BACTRIM, ZELITREX, TRIFLUCAN, TRANXENE, PREDNISOLONE, PROZAC, NEXIUM. Patient died on 02/14/2008.

Mabcampath Side Effects Report #5777053-1
Mabcampath side effect was reported by a Physician from UNITED KINGDOM on June 16, 2008. Male patient, 70 years of age, weighting 121.3 lb, was diagnosed with chronic lymphocytic leukaemia, bronchopulmonary aspergillosis, allergy prophylaxis and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: agranulocytosis, bronchopulmonary aspergillosis, cough, hepatic function abnormal, neutropenia, pyrexia. Mabcampath dosage: unknown. During the same period patient was treated with VORICONAZOLE, CHLORPHENIRAMINE MALEATE, HYDROCORTISONE. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #6017481-2
Mabcampath side effect was reported by a Physician from FRANCE on Dec 17, 2008. Male patient, 59 years of age, weighting 172.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cough, histiocytosis haematophagic, pyrexia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN, VALACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CALCIUM FOLINATE, AMLODIPINE, PRAVASTATIN, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.


Mabcampath Side Effects Report #6015281-0
Mabcampath side effect was reported by a Physician from FRANCE on Dec 09, 2008. Male patient, 52 years of age, weighting 189.6 lb, was diagnosed with chronic lymphocytic leukaemia, infection prophylaxis, antiviral prophylaxis and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: chills, cytokine release syndrome, dermatitis allergic, injection site rash, orthostatic hypotension, pyrexia, vomiting. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN, BACTRIM, ZELITREX, ZYLORIC, PRIMPERAN. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #5776416-8
Mabcampath side effect was reported by a Physician from GERMANY on May 19, 2008. Female patient, 70 years of age, weighting 130.1 lb, was diagnosed with adult t-cell lymphoma/leukaemia, antiviral prophylaxis, antibiotic prophylaxis, antifungal prophylaxis, hypertension and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cough, cytomegalovirus infection , pyrexia. Mabcampath dosage: unknown. During the same period patient was treated with ACIC, COTRIM, DIFLUCAN, ENALAPRIL MALEATE. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #5320747-2
Mabcampath side effect was reported by a Consumer or non-health professional from CANADA on May 03, 2007. Female patient, 53 years of age, was treated with Mabcampath. After drug was administered, patient experienced the following side effects: gait disturbance, injection site erythema, injection site mass, injection site pain, injection site swelling, pyrexia, skin reaction. Mabcampath dosage: 3 MG, DOSE ESCALATION. During the same period patient was treated with TYLENOL, BENADRYL. Patient was hospitalized. Patient recovered.